Minimum Floor. In no event will the Net Sales of a given Licensed Product in a country used to calculate (a) Royalties due and payable by Sarepta to Arrowhead under Section 8.4 (Royalties) in a given Calendar Quarter for such Licensed Product in such country be reduced to less than [***]% of the Net Sales of such Licensed Product in such country in such Calendar Quarter as a result of the aggregate reductions permitted pursuant to Section 8.5.1 (Reduction for No Valid Claim), Section 8.5.2 (Reduction for Generic Competition), Section 8.5.3 (Third Party Payments), [***].
Appears in 1 contract
Sources: Exclusive License and Collaboration Agreement (Sarepta Therapeutics, Inc.)
Minimum Floor. In no event will the Net Sales of a given Licensed Product in a country used to calculate (a) Royalties due and payable by Sarepta to Arrowhead under Section 8.4 (Royalties) in a given Calendar Quarter for such Licensed Product in such country be reduced to less than [***]% of the Net Sales of such Licensed Product in such country in such Calendar Quarter as a result of the aggregate reductions permitted pursuant to Section 8.5.1 8.5.1 (Reduction for No Valid Claim), Section 8.5.2 8.5.2 (Reduction for Generic Competition), Section 8.5.3 (Third Party Payments), [***].
Appears in 1 contract
Sources: Exclusive License and Collaboration Agreement (Arrowhead Pharmaceuticals, Inc.)